We are one of the world’s first Oxford Nanopore Technologies certified sequencing providers. With our extensive knowledge we can offer solutions that cover the whole process of going from a biological sample to a complete genome sequence and annotation. Future Genomics Technologies, founded in 2017, is a collaboration between biotech company BaseClear and Leiden University.
Leiden, Netherlands
Founded in 2017
1-10 Employees
Working industry
Biotechnology
Type of company
Manufacturer
Ownership structure
Privately Held
Locations
1 Headquarter
Number of products
8 Products
Number of services
1 Service
Specialised areas
Nanopore sequencing, Bioinformatics, Nucleic acid extraction, Biotechnology
Future Genomics Technologies offers a wide range of products and services
Product
European eel genome - Future Genomics Technologies
Go to product >
Product
Portfolio - Future Genomics Technologies
Go to product >
Product
Nanopore sequencing technology - Future Genomics Technologies
Go to product >
Service
Solutions - Future Genomics Technologies
Go to product >
Product
Sequencing by synthesis technology - Future Genomics Technologies
Go to product >
Product
King cobra - Future Genomics Technologies
Go to product >
Product
Yeast genome - Future Genomics Technologies
Go to product >
Product
Knowledge - Future Genomics Technologies
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Netherlands
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Future Genomics Technologies operates in 1 country around the world
Get an overview of the locations of Future Genomics Technologies
Location
Country
State
City
Headquarter
Netherlands
South Holland
Leiden
Some frequent questions that have been asked about Future Genomics Technologies
Where is Future Genomics Technologies located?
The company headquarter of Future Genomics Technologies is located in Leiden, South Holland, Netherlands. It's worth noting, that the company may have more locations
How many employees does Future Genomics Technologies approximately have?
As of the latest available information Future Genomics Technologies has around 1-10 employees worldwide.
When was Future Genomics Technologies founded?
Future Genomics Technologies was founded in 2017
In which industries does Future Genomics Technologies mainly work?
The company Future Genomics Technologies has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to Future Genomics Technologies
Oxford Nanopore Technologies
Oxford, United Kingdom
251-500 Employees
2005
Our goal is to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our goal is to open up new applications that have a profound, positive impact on society, by providing a new generation of accessible technology. Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins. Oxford Nanopore makes a novel generation of DNA/RNA sequencing technology that provides rich data, is fast, accessible and easy to use. Oxford Nanopore Technologies plc was founded in 2005 as a spin-out from the University of Oxford. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market. Oxford Nanopore is a public company, headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India.
Novogene
Beijing, China
501-1000 Employees
2011
Novogene uses leading technology from Illumina, Pacific Biosciences, Oxford Nanopore and Life Technologies, in our state-of-the-art sequencing centers in California (USA), Cambridge (UK), Singapore and China. Reliable and high quality NGS data is a key component in genomics research. At Novogene, we use the most effective technology available from world leading providers including Illumina NovaSeq 6000, HiSeq, Oxford Nanopore, Ion Torrent , PacBio Revio and PacBio Sequel platforms. Over the years our NGS labs have developed optimized NGS processes and protocols to ensure the best possible scientific outcome for your research. Not only do we offer state of the art NGS technology, we also have the largest sequencing capacity in the world with an annual throughput of over 280,000 human WGS samples.
1010Genome
Singapore, Singapore
1-10 Employees
2015
We are a group of genomics enthusiast working towards a common goal of providing quality and quick next generation sequencing services and bioinformatics data analysis services. At 1010Genome we handle all sequencing technologies equally well. We provide sequencing services for Illumina, Ion Torrent, Pacbio, Oxford Nanopore, 10xGenomics and Sanger platforms. At 1010Genome, we understand the value of time in research. At 1010Genome, we are at the forefront of genomics, specializing in Next-Generation Sequencing (NGS) and advanced bioinformatics solutions. Our mission is to unlock the mysteries of the genome, enabling researchers and clinicians to make groundbreaking discoveries that shape the future of healthcare and scientific understanding. We deliver fast quality sequencing services at affordable rates across multiple next generation sequencing platforms such as, Illumina, Pacbio, Oxford Nanopore, Element & ParseBio. We are proud of our work and the results we have achieved for our clients.
Eurofins Genomics
Huntsville, United States
251-500 Employees
1990
Eurofins Genomics is part of Eurofins Scientific Group, an international provider of genomic services established around the core business lines of next generation sequencing, custom DNA sequencing, oligonucleotides, siRNA and gene synthesis. The company's main mission is focused on customer convenience and high quality services in industrial scale for the life science industries and academic research institutions around the world. Our NGS projects are being delivered using advanced Illumina NextSeq500 platform, HiSeq2500, MiSeq, PacBio sequel with high performance computational infrastructure. The laboratory and production facility has established profound know-how and proprietary protocols to cover a broad range of applications. Our production facility is ISO 9001: 2015 certified, which ensures you get the highest quality of products and services. Eurofins Genomics India's prime goal is to provide its customers with high-quality services, accurate results in fast turnaround time. With over 30,000 staff in over 375 laboratories across 41 countries, Eurofins Scientific is the world leader in food, environment, genomics and pharmaceutical products testing. Applied services for optimisation of production strains, organisms, processes and products.
AGTC Genomics
Malaysia
11-50 Employees
2021
Our goal is to help solve the mysteries of how diseases are induced by genetics and epigenetics, and facilitate the advancement of precision medicine. Our products and services will enable consumers, researchers and clinicians to explore DNA on an entirely new scale, helping them to make informed decisions. We are a company at the intersection of biology and technology. We provide access to the world’s most advanced sequencing facility, no matter how large or small your organization is or where you are located in the world. We are dedicated to advancing genomic research and improving patient outcomes through our trusted services, and we are proud to be a partner of choice for some of the most respected institutions in the world. AGTC Genomics is dedicated to innovation, quality, rigor and transparency, providing outstanding solutions and support for human genome biomarker discovery. AGTC Genomics is a leading genomic center in the field of next-generation sequencing (NGS). Equipped with the latest world-leading technology platforms and professional scientific staff, AGTC Genomics is dedicated to assisting our clients while accelerating the precision medicine research and cancer diagnostics.
miBiome Therapeutics LLP
Mumbai, India
11-50 Employees
2019
We are an advanced science and deep tech start-up comprising of a passionate group of experienced scientists, doctors, business professionals and young coders. We are unlocking the power of genomics through deep technology in every sector. Our team of Next-Generation Sequencing (NGS) experts are always there to sequence DNA to understand life, disease, environment and more. Our team of highly qualified PhD experts can help navigate your sequencing journey.